Examine research linking sleep apnea to gut-derived signals that may drive cardiovascular disease and suggest microbiome-targeted therapeutic opportunities.
Key Takeaways
- Gut-heart connection that may explain sleep apnea's cardiovascular risk
- Disabling the bile acid receptor FXR in mice sharply reduced arterial plaque buildup
- Findings point to microbiome and bile-acid signaling as potential treatment targets